CD8A and nonpapillary renal cell carcinoma: Finally, we tested whether the enriched NF-κB activity in late dysfunctional CD8+ T cells—specifically, the NF-κB-driven pro-apoptotic transcriptional program—was predictive of clinical outcome in human ccRCC.